Company News
Sarda Proteins Board Meeting on Q4 FY26 Results
Sarda Proteins schedules board meeting on April 30, 2026 to approve audited standalone financial results for Q4 and full year FY26.
Trading window for company securities closed from April 1, 2026 and
